Copyright
©The Author(s) 2025.
World J Stem Cells. Jan 26, 2025; 17(1): 97905
Published online Jan 26, 2025. doi: 10.4252/wjsc.v17.i1.97905
Published online Jan 26, 2025. doi: 10.4252/wjsc.v17.i1.97905
Table 1 Summary of different mesenchymal stem cell types in endometrial injury treatment
MSC type | Source | Mechanisms in endometrial repair | Key findings in endometrial injury studies | Ref. |
Umbilical cord-derived MSCs | Endometrium | Proliferation, anti-fibrosis, angiogenesis | Support for endometrial regeneration by differentiating into functional endometrial cells | [85] |
Bone marrow-derived MSCs | Bone marrow | Anti-inflammation, immunomodulation | Reduction of fibrosis and improvement in endometrial thickness and vascularization in preclinical models | [86] |
Adipose tissue-derived MSCs | Adipose tissues | Paracrine signaling, anti-apoptosis | Significant potential in mitigating fibrosis and enhancing cellular regeneration | [87] |
Amniotic MSCs | Amniotic membranes | Immunomodulation, anti-fibrosis | Success in reducing inflammation and supporting tissue repair of the endometrium in experimental settings | [88] |
Menstrual blood-derived MSCs | Menstrual blood | Angiogenesis, epithelial-mesenchymal transition | Known for high proliferative potential and efficacy in improving endometrial receptivity and vascular repair | [89] |
Table 2 A summary of the literature on human umbilical cord mesenchymal stem cells and their exosomes in endometrial injury repair
No. | MSC origin | Vehicle type | Carrier | Stem cell transplant method | Model | Target (gene/pathway) | Biological functions | Reproductive outcome | Ref. |
1 | HucMSC | NA | HA/Gel hydrogel | Intrauterine injection | Endometrial mechanical injury rat | MEK/ERK1/2 | Fibrosis; inflammation; migration; proliferation | Endometrial thickness; number of glands; endometrial vessels; embryo implantation rate; live birth rate | [30] |
2 | HucMSC | NA | NA | NA | HESC | CCL2, HGF | Migration; invasion | NA | [90] |
3 | HucMSC | Exosome | NA | Femoral vein injection | Endometrial 95% ethanol injury rat | MiR-202-3p/MMP11 | ECM remodeling | NA | [65] |
4 | HucMSC | NA | GelMA/SerMA | Intrauterine injection | Endometrial 95% ethanol injury mouse | CD31, CK18, Ki67, vimentin, caspase 3 | Angiogenesis; proliferation; apoptosis; fibrosis | Endometrial thickness; embryo implantation rate | [58] |
5 | T10-HucMSC | Exosome | NA | Intrauterine injection | HESC treated with TGF-β endometrial mechanical injury rat | MiR-543N-cadherin α-SMA FN1 | Fibrosis; EMT; differentiation; apoptosis; migration | NA | [59] |
6 | HucMSC treated with TGF-β1 | Exosome | Cross-linked sodium hyaluronate | Intrauterine injection | Endometrial 95% ethanol injury rat | TGF-β1/Smad2/3 | Angiogenesis; fibrosis; proliferation; migration; collagen remodeling | Endometrial thickness; number of glands; embryo implantation rate | [60] |
7 | HucMSC | Exosome | NA | NA | EEC injury induced by hypoxia | MiR-663a/CDKN2A | Proliferation; apoptosis; migration; EMT | NA | [61] |
8 | T10-HucMSC | Exosome | NA | Intrauterine injection | Endometrial 95% ethanol injury mouse | HOXA10 | Fibrosis; angiogenesis; apoptosis | Endometrial thickness; number of glands; embryo implantation rate; Endometrial receptivity | [62] |
9 | UC-MSCbFGF | NA | Collagen scaffolds | Intrauterine injection | Uterine full-thickness defect rat | NA | Inflammation; angiogenesis; proliferation; regeneration | Endometrial thickness; embryo implantation rate | [91] |
10 | HucMSC | NA | PF-127 | Intrauterine injection | Endometrial 95% ethanol injury rat | IL-1β, bFGF, EGF, HGF | Angiogenesis; inflammation; fibrosis | Endometrial thickness; number of glands | [65] |
11 | HucMSC | NA | SF-SIS scaffolds | Transplanted in situ | Uterine full-thickness defect mouse | circPTP4A2/miR-330-5p/PDK2 | Fibrosis; mitochondrial metabolism | Number of glands; endometrial fibrosis area | [66] |
12 | HucMSC | NA | NA | Tail vein injection versus intrauterine injection | Endometrial 95% ethanol injury rat | IL-1β, TNF-α, bFGF | Angiogenesis; inflammation | Number of glands; endometrial receptivity | [92] |
13 | HucMSC | Exosome | NA | Tail vein injection | Mifepristone-induced HESC injury endometrial 95% ethanol injury rat | Integrin alpha, thrombospondin, laminin, collagen, VWF | ECM remodeling; protein degradation and absorption; inflammation; proliferation; apoptosis; migration; adhesion | Endometrial morphology and thickness; number of glands; endometrial fibrosis area; embryo implantation rate | [68] |
14 | HucMSC | NA | NA | NA | Endometrial mechanical injury mouse | MiR-455-5p/SOCS3/JAK/STAT455 | Fibrosis; proliferation; cell cycle progression | Number of glands; endometrial fibrosis area | [69] |
15 | HucMSC | NA | AAM | Transplanted in situ | Endometrial 95% ethanol injury rat | Keratin, vimentin, integrin β3, VEGF, MMP9 | ECM remodeling; proliferation; migration; inflammation | Endometrial morphology and thickness; number of glands; endometrial receptivity; pregnancy rate; birth weight; number of neonatal rats | [70] |
16 | HucMSC | NA | Collagen scaffolds | Hysteroscopic transplantation | 16 females experiencing infertility with thin endometrium (embryo transfers ≤ 5.5 mm) | ERα, PR | Angiogenesis; proliferation; hormone response; differentiation; angiogenesis | Endometrial thickness; uterine receptivity (endometrial volume and subendometrial blood flow); number of glands; miscarriage rate; pregnancy rate; live birth rate; birth defects | [55] |
17 | HucMSC | NA | NA | Intraperitoneal injection | Endometrial mechanical injury rat | TGF-β1/Smad3 | Fibrosis; angiogenesis; differentiation; migration | Endometrial thickness; endometrial fibrosis area; number of glands; pregnancy rate; number of fetuses | [93] |
18 | HucMSC | Exosome | Collagen scaffolds | Transplanted in situ | Endometrial mechanical injury rat | MiR-223-3p | Immunomodulation (infiltration and polarization of macrophages); collagen remodeling; hormone response; inflammation; endometrial regeneration; fibrosis; angiogenesis | Pregnancy rate | [71] |
19 | HucMSC | NA | HA-GEL | Transplanted in situ | Endometrial mechanical injury rhesus monkey | IL-4, IGF-1, EGF, IFN, VEGF | Fibrosis; angiogenesis; inflammation | Endometrial morphology and thickness; number of glands; endometrial receptivity | [84] |
20 | HucMSC | NA | Collagen scaffolds | Intrauterine injection | Endometrial mechanical injury rat | ER, CTGF, TGFβ1, FGF2 | Proliferation; hormone response; fibrosis | Number of glands; endometrial fibrosis area | [94] |
21 | HucMSC | Exosome | NA | NA | OGD/R-induced injured EEC | TLR4/RelA | Cell viability; cell death; inflammation | NA | [95] |
22 | HucMSC | NA | Collagen scaffolds | Transplanted in situ | HESC endometrial mechanical injury rat | TGF-b1, PDGF-BB, VEGF-A, Ki67 | Proliferation; apoptosis; hormone response; regeneration; collagen remodeling; fibrosis; angiogenesis | Endometrial morphology and thickness; number of glands; pregnancy rate | [96] |
23 | HucMSC | NA | Collagen scaffolds | Transplanted in situ (spread onto an 18F Foley catheter and placed into the uterine cavity) | 26 females experiencing infertility with recurrent IUA | ERα, vimentin, Ki67, VWF, ΔNP63 | Proliferation; differentiation; angiogenesis | IUA score; endometrial thickness; ongoing pregnancy rate (> 12 weeks active fetus); live birth rate; menstrual volume; miscarriage rate; histological changes in endometrium | [97] |
24 | HucMSC | NA | NA | Tail vein injection | Endometrial 95% ethanol injury rat | VEGF-A, MMP9, IFN-γ, TNF-α, IL-2, α-SMA, TGF-β | Fibrosis; proliferation; angiogenesis; inflammation; differentiation; regeneration; fibrosis | Endometrial morphology and thickness; number of glands; endometrial fibrosis area; pregnancy rate | [98] |
25 | HucMSC | NA | Collagen scaffolds | Intrauterine injection | Uterine full-thickness defect rat | MMP-9, α-SMA, VWF | Adhesion; migration; differentiation; angiogenesis; differentiation | Endometrial morphology and thickness; number of glands; pregnancy rate; number, size, and weight of fetuses | [56] |
26 | HucMSC | Exosome | NA | NA | Mifepristone-induced HESC injury | PTEN/AKT | Proliferation; apoptosis | NA | [57] |
27 | HucMSC | Exosome | NA | NA | Mifepristone-induced HESC injury | MiR-7162-3p/APOL6 | Apoptosis; regeneration | NA | [58] |
28 | HucMSC | Exosome | NA | NA | HESC treated with TGF-β1 | MiR-145-5p/ZEB2 | Fibrosis | NA | [54] |
29 | HucMSC | Exosome | NA | NA | HESC | NA | Proliferation | NA | [99] |
30 | WJMSC | NA | NA | Intrauterine injection | 1 female experiencing infertility with IUA; 1 female experiencing infertility with endometrial atrophy | NA | NA | Endometrial thickness; pregnancy rate | [80] |
31 | WJMSC | NA | NA | NA | Mifepristone-induced HESC injury | Circ6401miR-29b-1-5p/RAP1B | Angiogenesis; apoptosis | NA | [100] |
32 | WJMSC | NA | NA | Intrauterine injection | Endometrial 95% ethanol injury rat | TGF-β1 Rho/ROCK | Angiogenesis; regeneration | Endometrial thickness; number of glands | [101] |
33 | hAMSC | NA | NA | NA | Mifepristone-induced HESC injury | VEGF, caspase 3, caspase 8 | Proliferation; apoptosis | NA | [102] |
34 | hAMSC | NA | NA | Intrauterine injection | Endometrial 95% ethanol injury rat | Notch pathway | Differentiation; regeneration and repair | NA | [103] |
35 | hAMSC | NA | NA | Intrauterine injection | Endometrial mechanical injury rat | TNFα, IL-1β, bFGF, IL-6, VEGF | Angiogenesis; regeneration | Endometrial thickness; number of glands; endometrial fibrosis area | [52] |
- Citation: Zhang WY, Wang HB, Deng CY. Advances in human umbilical cord mesenchymal stem cells-derived extracellular vesicles and biomaterial assemblies for endometrial injury treatment. World J Stem Cells 2025; 17(1): 97905
- URL: https://www.wjgnet.com/1948-0210/full/v17/i1/97905.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i1.97905